Country of Sales: JAPAN

For Maxillofacial and Plastic Surgery:ReBOSSIS-MT

Product Information

Brand Name:

ReBOSSIS-MS
ReBOSORB

Approval Number(Medical Device):

30300BZX0095A03

Approval Date:

August 5th, 2022

Reach Out to Our Distributor

Sales Consignment:
Teijin Medical Technologies Co., Ltd.
Address:

13th Floor, Osaka Mitsui Bussan Bldg.,2-3-33,
Nakanoshima, Kita-ku, Osaka 530-0005, Japan

TEL:

+81-86-279-6278

FAX:

+81-86-279-9510

ReBOSSIS Product Line

Country of Sales: Japan

For Orthopedic Surgery

ReBOSSIS-J

For Maxillofacial and Plastic Surgery

ReBOSSIS-MS

For Maxillofacial and Plastic Surgery

ReBOSSIS-MT

For Maxillofacial and Plastic Surgery

ReBOSSIS-MK

For Neurosurgery, Maxillofacial and Plastic Surgery

ReBOSSIS-MC

For Orthopedic Surgery

ReBOSSIS-JS

Cell Culture Substrate
Stem Cell Extraction Culture Sheet for Research

Efficient Cell Culturing and Cost Reduction
This innovation is
the crystallization of
our bioabsorbable
microfiber technology

Our microfiber scaffolding material manufacturing technology has garnered significant attention from universities, research institutions, and companies involved in regenerative medicine.
The already commercialized “Stem Cell Extraction Culture Sheet for Research” has been shown to accelerate cell proliferation when used as a scaffolding material for cell culture. Its high bioabsorbability allows for the cultured cell sheets to be implanted directly into the body. This innovative approach is expected to revolutionize cell culture, which has traditionally been time-consuming and costly.

PAGE TOP